Skip to content
TrustList
Verily logo
Venture capital firm

Verily

Precision health company with a data platform for research and care, plus medical devices work

Verily cover

About Verily

A health data platform with a medical devices history

Verily works in health technology, and its current site calls the business AI-native precision health. The present focus is a data platform that gathers scattered health information for researchers and care teams. Alongside that platform, the company has a medical devices team that has worked with partners on wearable products for people with chronic conditions.

The data platform

The platform is described as a single place for advanced analytics, workflow orchestration, AI deployment and governance. It works in stages. First it ingests, harmonizes and enriches data from many sources into a clinically informed model built on the FHIR standard. Security, privacy and auditability controls are said to travel with the data through its whole life. Teams can then connect to research-ready data, analysis tools and AI tooling for shared discovery, and place models, agents and predictions directly into governed research and care workflows. The company's stated aim is to move quickly from siloed health data to patient impact.

Who uses it

The site organizes its offer by audience: life sciences organizations, healthcare providers, public health bodies, payers and employers, and consumers. To research groups it offers tooling meant to cover every step from choosing a drug target to educating patients, and says analysis that used to take weeks can now finish in hours.

Work on glucose monitoring

Verily's earlier material centers on a joint project with a diabetes technology maker to produce a continuous glucose monitoring system, the Dexcom G7. According to that material, Verily contributed its skills in innovation and in miniaturizing electronics, which helped reduce the device's size by about sixty percent against its predecessor, giving an all-in-one, discreet wearable. The company reports that the monitor reached markets in Europe and several other countries after receiving the CE Mark, and the United States after FDA clearance.

Connected care

Verily also ran Onduo, a virtual care platform for chronic conditions that includes health coaching and personalized tips. It positions glucose monitoring combined with a program like this as a way to deliver more individualized interventions. It describes its mission as making precision health accessible to everyone, every day.

TrustList summary

Verily is a health technology company. Its current site centres on a data platform that pulls together scattered health information so researchers and care teams can analyse it, and it also has a medical devices team.

What Verily offers

  • Data platform: ingests and harmonises varied health data into a FHIR-based model.
  • Governance: security, privacy and audit controls that stay with the data.
  • Analytics and AI: shared tools for research and for placing models into workflows.
  • Devices: it helped build the Dexcom G7 continuous glucose monitor.
  • Care programmes: chronic condition management such as Onduo.

Who it serves

Life sciences organisations and healthcare providers, including universities and hospital research groups.

Summary written by TrustList from the business's own published information, Nov 2026.

Ask TrustList to introduce you to Verily

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Verily

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Verily.

Verily alternatives

Similar listings buyers compare against this one.

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications

A blockchain infrastructure provider running validator nodes and staking services across proof-of-stake networks

Web3 investment manager backing early-stage blockchain founders across the Algorand ecosystem and beyond

A healthcare and life sciences venture capital firm investing since 1996